ArticleNature communications2020

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.

Jianbo Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.